Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study

BACKGROUNDA drug-drug interaction (DDI) may occur when transitioning from intravenous P2Y12 inhibition with cangrelor to oral P2Y12 inhibition with prasugrel. However, this has never been tested in patients undergoing percutaneous coronary intervention (PCI).OBJECTIVESThis study sought to rule out a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JACC. Cardiovascular interventions 2023-10, Vol.16 (20), p.2528-2539
Hauptverfasser:	Franchi, Francesco, Rollini, Fabiana, Ortega-Paz, Luis, Been, Latonya, Giordano, Salvatore, Galli, Mattia, Ghanem, Ghussan, Garabedian, Haroutioun, Al Saleh, Tala, Uzunoglu, Ekin, Rivas, Andrea, Pineda, Andres M, Suryadevara, Siva, Soffer, Daniel, Zenni, Martin M, Mahowald, Madeline, Reiter, Birgit, Jilma, Bernd, Angiolillo, Dominick J
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!